Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Neutron Science (21)
- Advanced Manufacturing (1)
- Biology and Environment (25)
- Building Technologies (1)
- Clean Energy (30)
- Climate and Environmental Systems (1)
- Computational Biology (1)
- Computational Engineering (3)
- Computer Science (15)
- Energy Frontier Research Centers (1)
- Fusion and Fission (3)
- Fusion Energy (2)
- Isotopes (1)
- Materials (51)
- Materials for Computing (12)
- Mathematics (1)
- National Security (19)
- Nuclear Science and Technology (2)
- Quantum information Science (7)
- Supercomputing (100)
News Topics
- (-) Computer Science (13)
- (-) Nanotechnology (10)
- 3-D Printing/Advanced Manufacturing (6)
- Advanced Reactors (1)
- Artificial Intelligence (6)
- Big Data (2)
- Bioenergy (6)
- Biology (6)
- Biomedical (12)
- Biotechnology (1)
- Chemical Sciences (3)
- Clean Water (2)
- Climate Change (1)
- Composites (1)
- Coronavirus (8)
- Cybersecurity (1)
- Decarbonization (2)
- Energy Storage (6)
- Environment (8)
- Fossil Energy (1)
- Frontier (1)
- Fusion (1)
- High-Performance Computing (2)
- Machine Learning (3)
- Materials (14)
- Materials Science (23)
- Mathematics (1)
- Microscopy (3)
- National Security (2)
- Neutron Science (101)
- Nuclear Energy (3)
- Physics (9)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (7)
- Security (2)
- Space Exploration (3)
- Summit (6)
- Sustainable Energy (2)
- Transportation (5)
Media Contacts
A team of scientists, led by University of Guelph professor John Dutcher, are using neutrons at ORNL’s Spallation Neutron Source to unlock the secrets of natural nanoparticles that could be used to improve medicines.